1-156135913-G-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_170707.4(LMNA):c.949G>T(p.Glu317*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,384 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Synonymous variant affecting the same amino acid position (i.e. E317E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_170707.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dilated cardiomyopathy 1AInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet
- familial partial lipodystrophy, Dunnigan typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- Hutchinson-Gilford progeria syndromeInheritance: AD, SD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- restrictive dermopathy 2Inheritance: AR, AD Classification: DEFINITIVE, LIMITED Submitted by: G2P
- Emery-Dreifuss muscular dystrophy 2, autosomal dominantInheritance: SD, AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- atrioventricular blockInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- heart-hand syndrome, Slovenian typeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P
- Charcot-Marie-Tooth disease type 2B1Inheritance: AR, AD Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- Emery-Dreifuss muscular dystrophy 3, autosomal recessiveInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- mandibuloacral dysplasia with type A lipodystrophyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- atrial fibrillationInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- atypical Werner syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal dominant Emery-Dreifuss muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital muscular dystrophy due to LMNA mutationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- lethal restrictive dermopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- LMNA-related cardiocutaneous progeria syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive Emery-Dreifuss muscular dystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathy-hypergonadotropic hypogonadism syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal semi-dominant severe lipodystrophic laminopathyInheritance: SD Classification: SUPPORTIVE Submitted by: Orphanet
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_170707.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LMNA | NM_170707.4 | MANE Select | c.949G>T | p.Glu317* | stop_gained | Exon 6 of 12 | NP_733821.1 | ||
| LMNA | NM_005572.4 | MANE Plus Clinical | c.949G>T | p.Glu317* | stop_gained | Exon 6 of 10 | NP_005563.1 | ||
| LMNA | NM_001406985.1 | c.949G>T | p.Glu317* | stop_gained | Exon 6 of 13 | NP_001393914.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LMNA | ENST00000368300.9 | TSL:1 MANE Select | c.949G>T | p.Glu317* | stop_gained | Exon 6 of 12 | ENSP00000357283.4 | ||
| LMNA | ENST00000677389.1 | MANE Plus Clinical | c.949G>T | p.Glu317* | stop_gained | Exon 6 of 10 | ENSP00000503633.1 | ||
| LMNA | ENST00000368299.7 | TSL:1 | c.949G>T | p.Glu317* | stop_gained | Exon 6 of 12 | ENSP00000357282.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461384Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 726994 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. LMNA p.Glu317Ter This variant is novel, it has not been reported in peer reviewed literature to date. This nucleotide substitution is expected to create a premature stop codon and a truncated Lamin A/C protein. There are at least 10 different nonsense variants reported in the LMNA gene associated with various phenotypes, primarily dilated cardiomyopathy, conduction system disease, or muscular dystrophy (LGMD, EDMD) (Cowan J et al 2011, http://www.dmd.nl/lmna_seqvar.html). Geiger et al (2007) report a nearby nonsense variant (R321X) in a family with DCM and sudden death; three affected family members were genotyped and they all had the variant. mRNA and protein studies on patient skin fibroblasts and LV myocardium were consistent with mRNA mediated nonsense decay. Van Engelen et al (2005) reported another nonsense variant, p.Tyr259Ter segregating with limb-girdle muscular dystrophy in nine affected family members. A homozygous baby born to consanguineous heterozygous parents died at birth because of severe generalized muscular dystrophy. The variant is not listed in dbSNP or 1000 genomes (as of September 2011). No nonsense variants were identified in 47 healthy elderly individuals studied by Halaschek-Wiener et al (2009). This variant was not present in the NHLBI exome sequencing project data on LMNA, which includes variant calls on ~6500 individuals of European and African American descent (and, of note, there are currently no frameshift or nonsense variants in control individuals in this dataset, as of 6/14/2013). LMNA variants are frequently associated with dilated cardiomyopathy and conduction system disease. Patients with Emery-Dreifuss muscular dystrophy associated with LMNA variants have been reported with either dilated cardiomyopathy or a restrictive cardiomyopathy (Raffaele di Barletta et al 2000, Sanna et al 2003). However, we have not been able to find any cases of isolated restrictive cardiomyopathy due to LMNA variants.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at